Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults-Reference-Cited by-同舟云学术

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults

Published:2019-05 Issue:5 Volume:78 Page:382-392
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Green Christopher A.,Sande Charles J.,Scarselli Elisa,Capone Stefania,Vitelli Alessandra,Nicosia Alfredo,Silva-Reyes Laura,Thompson Amber J.,de Lara Catherine M.,Taylor Kathryn S.,Haworth Kathryn,Hutchings Claire L.,Cargill Tamsin,Angus Brian,Klenerman Paul,Pollard Andrew J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference57 articles.

1. Respiratory syncytial virus and influenza a infections in the hospitalized elderly;Falsey;J Infect Dis,1995

2. Acute respiratory tract infection in daycare centers for older persons;Falsey;J Am Geriatr Soc,1995

3. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial;McElhaney;Lancet Infect Dis,2013

4. Respiratory syncytial virus infection in older adults: an under-recognized problem;Branche;Drugs Aging,2015

5. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections;Lee;Clin Infect Dis An official publication of the infectious diseases society of America,2013

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B;Journal of Hepatology;2024-07

2. BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice;npj Vaccines;2024-03-08

3. Intranasal parainfluenza virus type 5 (PIV5)–vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study;Science Advances;2023-10-27

4. Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections;Pharmaceutical Research;2023-04-25

5. Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants;Expert Opinion on Pharmacotherapy;2023-04-06